icon
icon
icon
icon
Upgrade
icon

Activist Starboard Value Takes $1 Billion Stake in Pfizer

AInvestSunday, Oct 6, 2024 9:21 pm ET
1min read
Activist investor Starboard Value has taken a significant position in Pfizer, acquiring a roughly $1 billion stake in the U.S. drug giant. This move comes as Pfizer faces challenges with falling COVID-19 sales and competition for its drugs, prompting the company to seek changes to improve its performance. Starboard Value, led by Jeff Smith, is known for its involvement in various sectors, including technology, and has previously made efforts at companies such as Salesforce and Autodesk.


Starboard Value has reached out to former Pfizer executives Ian Read and Frank D'Amelio for assistance in its efforts to turn around the company's fortunes. Read, who served as Pfizer's CEO from 2010 to 2018, and D'Amelio, the former CFO from 2007 to 2021, have expressed interest in helping Starboard Value in its mission. The specifics of Starboard Value's plans and interactions with Pfizer remain unclear, but the company is expected to advocate for changes to address the drugmaker's current challenges.


Pfizer's stock has been roughly cut in half from its record high in late 2021, following the company's delivery of the world's first COVID-19 vaccine. While the company's shares have been little changed so far this year, they have not kept pace with the S&P 500's 21% rise. Pfizer's CEO, Albert Bourla, has been under pressure to right the ship at the drugmaker, particularly after overestimating future demand for pandemic-related products as the health emergency subsided.

Starboard Value's involvement in Pfizer comes at a critical juncture for the company, as it grapples with falling COVID-19 sales and the need to diversify its revenue streams. The activist investor's influence could potentially impact Pfizer's M&A activities, cost-cutting measures, and long-term financial performance. As Starboard Value works to address Pfizer's challenges, the company's future will depend on its ability to adapt and innovate in the face of changing market dynamics and competitive pressures.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.